A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas Article

cited authors

  • Butowski, Nicholas; Lamborn, Kathleen R; Lee, Bee L; Prados, Michael D; Cloughesy, Timothy; DeAngelis, Lisa M; Abrey, Lauren; Fink, Karen; Lieberman, Frank; Mehta, Minesh; Robins, H Ian; Junck, Larry; Salazar, Andres M; Chang, Susan M

fiu authors

publication date

  • January 1, 2009

keywords

  • ADJUVANT CHEMOTHERAPY
  • Adjuvant therapy
  • Anaplastic glioma
  • CANCER
  • CARBOXYMETHYLCELLULOSE
  • Clinical Neurology
  • L-LYSINE
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • Neurosciences & Neurology
  • Oncology
  • POLYINOSINIC-POLYCYTIDYLIC ACID
  • Poly-ICLC
  • RADIATION-THERAPY
  • RADIOTHERAPY
  • Radiation therapy
  • Science & Technology
  • TOLL-LIKE RECEPTOR-3
  • VINCRISTINE PCV

Digital Object Identifier (DOI)

start page

  • 183

end page

  • 189

volume

  • 91

issue

  • 2